Possible role of selective serotonin reuptake inhibitor sertraline on oxidative stress responses

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 4, 2014, Pages 477-484

  Battal, D ^a   Yalin, S ^a   Eker, E D ^a   Aktas, A ^a   Sahin, N O ^a   Cebo, M ^b   Berkoz M ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Antioxidant; Biomarker; Oxidative stress; Sertraline

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CATALASE; MALONALDEHYDE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUPEROXIDE DISMUTASE; BIOLOGICAL MARKER; OXIDIZING AGENT;

ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BRAIN TISSUE; CONTROLLED STUDY; DEPRESSION; DRUG MEGADOSE; DRUG POTENCY; ENZYME ACTIVITY; LIPID PEROXIDATION; LOW DRUG DOSE; MALE; NERVE ENDING; NONHUMAN; OXIDATIVE STRESS; PROGNOSIS; RAT; ANIMAL; BLOOD; BRAIN; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ANIMALS; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; BRAIN; CATALASE; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDANTS; OXIDATIVE STRESS; RATS, WISTAR; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SUPEROXIDE DISMUTASE;

EID: 84896977324     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. ABDEL SALAM OM, MORSY SMY, SLEEM AA. The effect of different antidepressant drugs on oxidative stress after lipopolysaccharide administration in mice. EXCLI J 2011; 10: 290-302.
2. GOLDSTEIN BJ, GOODNICK PJ. Selective serotonin reuptake inhibitors in the treatment of affective disorders-III. Tolerability, safety and pharmacoeconomics. J Psychopharmacol 1998; 12: 55-87.
3. SÁNCHEZ C, HYTTEL J. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cell Mol Neurobiol 1999; 19: 467-489.
4. KITAICHI Y, INOUE T, NAKAGAWA S, BOKU S, KAKUTA A, IZUMI T, KOYAMA T. Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. Eur J Pharmacol 2010; 647: 90-96.
5. MACQUEEN G, BORN L, STEINER M. The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders. CNS Drug Rev 2001; 7: 1-24.
6. PENG Q, MASUDA N, JIANG M, LI Q, ZHAO M, ROSS CA, DUAN W. The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp Neurol 2008; 210: 154-163.
7. DUAN W, PENG Q, MASUDA N, FORD E, TRYGGESTAD E, LADENHEIM B, ZHAO M, CADET JL, WONG J, ROSS CA. Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol Dis 2008; 30: 312-322.
8. IMLAY JA. Cellular Defenses Against Superoxide and Hydrogen Peroxide. Annu Rev Biochem 2008; 77: 755-776.
9. BEHR GA, MOREIRA JC, FREY BN. Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder. Oxid Med Cell Longev 2012; 609421.
10. HALLIWELL B. Oxidative stress and neurodegeneration. where are we now? J Neurochem 2006; 97: 1634-1658.
11. VALKO M, LEIBFRITZ D, MONCOL J, CRONIN MTD, MAZUR M, TELSER J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
12. BILICI M, EFE H, KÖRO LU MA, UYDU HA, BEKARO LU M, DEGER O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001; 64: 43-51.
13. JANERO DR. Malondialdehyde and thiobarbituric acidreactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990; 9: 515-540.
14. ESTERBAUER H, SCHAUR RJ, ZOLLNER H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
15. CLARKE DD, SOKOLOFF L. Circulation and energy metabolism of the brain. In Basic neurochemistry: Molecular, cellular and medical aspects, Siegel GJ, Agranoff BW, Albers RW, Fisher SK, Uhler MD (eds), Lippincott-Raven: Philadelphia, 1999; pp. 637-639.
16. SARANDOL A, SARANDOL E, EKER SS, ERDINC S, VATANSEVER E, KIRLI S. Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems. Human Psychopharmacol 2007; 2: 67-73.
17. RICE ME, FORMAN RE, CHEN BT, AVSHALUMOV MV, CRAGG SJ, DREW KL. Brain antioxidant regulation in mammals and anoxia-tolerant reptiles: balanced for neuroprotection and neuromodulation. Comp Biochem Physiol Part C 2002; 133: 515-525.
18. EU GUIDELINES FOR LABORATORY ANIMALS. Available at: http://ec.europa.eu/ environment/chemicals/lab-a nimals/home-en.htm (Last Accessed Date: 14 April 2013)
19. YAGI K. Simple procedure for specific enzyme of lipid hydroperoxides in serum or plasma. Methods Mol Biol 1998; 108: 107-110.
20. SUN Y, OBERLEY LW, YING L. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34: 497-500.
21. AEBI H. Catalase in vitro. Methods Enzymol 1984; 105: 121-126.
22. ECKERSON HW, WYTE CM, LA DU BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126-1138.
23. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
24. LOBATOA KR, CARDOSOA CC, BINFAREA WR, BUDNIA J, WAGNERA CLR, BROCARDOA PS, SOUZAB LF, BROCARDOB C, FLESCHB S, FREITAS AE, DAFREB AL, RODRIGUESA ALS. αTocopherol administration produces an antidepressant-like effect in predictive animal models of depression. Behav Brain Res 2010; 209: 249-259.
25. TSUBOI H, SHIMOI K, KINAE N, OGUNI I, HORI R, KOBAYASHI F. Depressive symptomsare independently correlated with lipid peroxidation in a female population:comparison with vitamins and carotenoids. J Psychosom Res 2004; 56: 53-58.
26. TSUBOI H, TATSUMI A, YAMAMOTO K, KOBAYASHI F, SHIMOI K, KINAE N. Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. J Affect Disord 2006; 91: 63-70.
27. SEJIMA H, ITO M, KISHI K, TSUDA H, SHIRAISHI H. Regional excitatory and inhibitory amino acid concentrations in pentylenetetrazol kindling and kindled rat brain. Brain Dev 1997; 19: 171-175.
28. AGARWAL NB, JAIN S, AGARWAL NK, MEDIRATTA PK, SHARMA KK. Modulation of pentylenetetrazole-induced kindling and oxidative stress by curcumin in mice. Phytomedicine 2011; 18: 756-759.
29. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 2003; 8: 365-370.
30. KOTAN VO, SARANDOL E, KIRHAN E, OZKAYA G, KIRLI S. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1284-1290.
31. KEHRER JP. Free radicals as mediators in tissue injury and disease.Crit Rev Toxicol 1993; 23: 21-48.
32. DINU D, MARINESCU D, MUNTEANU MC, STAICU AC, COSTACHE M, DINISCHIOTU A. Modulatory effects of deltamethrin on antioxidant defense mechanisms and lipid peroxidation in Carassius auratus gibelio liver and intestine. Arch Environ Contam Toxicol 2010; 58: 757-764.
33. Jyoti A, Sethi P, Sharma D. Bacopa monniera prevents from aluminium neurotoxicity in the cerebral cortex of rat brain. J Ethnopharmacol 2007; 111: 56-62.
34. BHALLA P, DHAWAN DK. Protective role of lithium in ameliorating the aluminium-induced oxidative stress and histological changes in rat brain. Cell Mol Neurobiol 2009; 29: 513-521.
35. RAMANATHAN K, BALAKUMAR BS, PANNEERSELVAM C. Effects of ascorbic acidand a-tocopherol on arsenicinduced oxidative stress. Human Exp Toxicol 2002; 21: 675-680.
36. EL-DEMERDASH FM, YOUSEF MI, RADWAN FM. Ameliorating effect of curcumin on sodium arsenite-induced oxidative damage and lipid peroxidation in different rat organs. Food Chem Toxicol 2009; 47: 249-254.
37. REDDY ST, WADLEIGH DJ, GRIJALVA V, NG C, HAMA S, GANGOPADHYAY A, SHIH DM, LUSIS AJ, NAVAB M, FOGELMAN AM. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 2001; 21: 542-547.
38. NG CJ, WADLEIGH DJ, GANGOPADHYAY A. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J Biol Chem 2001; 276: 44444-44449.
39. RAMEZANI A, GOUDARZI I, LASHKARBOLOUKI T, GHORBANIAN MT, SALMANI ME, ABRARI K. Neuroprotective effects of the 17β-estradiol against ethanol-induced neurotoxicity and oxidative stress in the developing male rat cerebellum: biochemical, histological and behavioral changes. Pharmacol Biochem Behav 2011; 100: 144-151.
40. BERGAMINI CM, GAMBETTI S, DONDI A, CERVELATTI C. Oxygen, reactive oxygen species and tissue damage. Curr Pharm Des 2004; 10: 1611-1626.
41. HERKEN H, GUREL A, SELEK S, ARMUTCU F, OZEN ME, BULUT M. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 2007; 38: 247-252.